跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 933 条关于
“TVGN 489”
全部
933
临床试验
540
药物
291
机构
8
资讯
94
去年
Tevogen's TVGN-489 T Cell Therapy Achieves $9-11 Billion Valuation Following Successful COVID-19 Trial
去年
Tevogen Bio's TVGN 489 Shows Promise in High-Risk COVID-19 Patients
去年
Tevogen Bio Expands TVGN 489 Pipeline to Include Patients 65 and Older, Targeting $1 Billion Launch Year Revenue
去年
Tevogen Bio Presents ExacTcell Platform to BARDA as Potential Rapid-Response Viral Countermeasure
去年
Tevogen Bio Files Patent for Novel T Cell Vaccine Targeting Entire Viral Genomes
去年
Technology-Assisted Health Coaching Fails to Achieve Significant Weight Loss in Primary Care Trial
3个月前
Genentech Lays Off 103 Employees in Fifth Round of Cuts Since Mid-2025, Three VPs Among Casualties
6个月前
Tevogen Bio's AI Platform Achieves Breakthrough in Drug Target Prediction with 92% Accuracy
去年
Belumosudil Shows Promise in Treating Heavily Pretreated Chronic Graft-versus-Host Disease
去年
Biohaven Secures $600 Million Non-Dilutive Funding from Oberland Capital for Rare Disease Drug Development
第 1 页,共 10 页
上一页
下一页